Literature DB >> 3182484

Role of muscle loss in the age-associated reduction in VO2 max.

J L Fleg1, E G Lakatta.   

Abstract

A progressive decline in maximal O2 consumption (VO2max) expressed traditionally as per kilogram body weight generally occurs with advancing age. To investigate the extent to which this decline could be attributable to the age-associated loss of metabolically active tissue, i.e., muscle, we measured 24-h urinary creatinine excretion, an index of muscle mass, in 184 healthy nonobese volunteers, ages 22-87 yr, from the Baltimore Longitudinal Study of Aging who had achieved a true VO2max during graded treadmill exercise. A positive correlation was found between VO2max and creatinine excretion in both men (r = 0.64, P less than 0.001) and women (r = 0.47, P less than 0.001). As anticipated, VO2max showed a strong negative linear relationship with age in both men and women. Creatinine excretion also declined with age in men and women. When VO2max was normalized for creatinine excretion, the variance in the VO2max decline attributable to age declined from 60 to 14% in men and from 50 to 8% in women. Thus comparing the standard age regression of VO2max per kilogram body weight with that in which VO2max is normalized per milligram creatinine excretion, the decline in VO2max between a hypothetical 30 yr old and a 70 yr old was reduced from 39 to 18% in men and from 30 to 14% in women. We conclude that in both sexes, a large portion of the age-associated decline in VO2max in non-endurance-trained individuals is explicable by the loss of muscle mass, which is observed with advancing age.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182484     DOI: 10.1152/jappl.1988.65.3.1147

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  98 in total

1.  Influence of ageing on aerobic parameters determined from a ramp test.

Authors:  M A Babcock; D H Paterson; D A Cunningham
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

2.  Age and training effects on the lactate kinetics of master athletes during maximal exercise.

Authors:  J Massé-Biron; J Mercier; K Collomp; J M Hardy; C Préfaut
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

Review 3.  Aging and muscle function.

Authors:  Y Aoyagi; R J Shephard
Journal:  Sports Med       Date:  1992-12       Impact factor: 11.136

4.  Allometric scaling of 6-min walking distance by body mass as a standardized measure of exercise capacity in healthy adults.

Authors:  Victor Zuniga Dourado; Mary Ann McBurnie
Journal:  Eur J Appl Physiol       Date:  2011-11-11       Impact factor: 3.078

5.  Neuromuscular adaptations to water-based concurrent training in postmenopausal women: effects of intrasession exercise sequence.

Authors:  Stephanie S Pinto; Cristine L Alberton; Natália C Bagatini; Paula Zaffari; Eduardo L Cadore; Régis Radaelli; Bruno M Baroni; Fábio J Lanferdini; Rodrigo Ferrari; Ana Carolina Kanitz; Ronei S Pinto; Marco Aurélio Vaz; Luiz Fernando M Kruel
Journal:  Age (Dordr)       Date:  2015-02-03

6.  Patterns of senescence in human cardiovascular fitness: VO2 max in subsistence and industrialized populations.

Authors:  Anne C Pisor; Michael Gurven; Aaron D Blackwell; Hillard Kaplan; Gandhi Yetish
Journal:  Am J Hum Biol       Date:  2013-09-10       Impact factor: 1.937

7.  Adaptations to endurance training in the healthy elderly: arm cranking versus leg cycling.

Authors:  S Pogliaghi; P Terziotti; A Cevese; F Balestreri; F Schena
Journal:  Eur J Appl Physiol       Date:  2006-06-24       Impact factor: 3.078

Review 8.  The frailty syndrome: definition and natural history.

Authors:  Qian-Li Xue
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 9.  Exercise intolerance.

Authors:  Dalane W Kitzman; Leanne Groban
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

Review 10.  Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training.

Authors:  Steven Hawkins; Robert Wiswell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.